Viewing Page 1 of 1 | Showing Results 1 - 2 of 2

Breakthrough lung cancer drug helps clinical trial patient

March 06, 2015

A breakthrough drug for treating the most common type of lung cancer was just approved by the Food and Drug Administration ahead of schedule following two successful clinical trials, including one that involved patients at Providence Cancer Center in Portland.

Conquer Cancer Foundation honors Providence Cancer Center for clinical trials

June 19, 2014

Where you live can make a difference in your cancer treatment. Local cancer patients benefit by having access to a large number of clinical trials. In fact, the Conquer Cancer Foundation of the American Society of Clinical Oncology recently honored Providence Oncology and Hematology Care Clinic at Providence Cancer Center for care that includes a large number of clinical trials offered to patients. 

Viewing Page 1 of 1 | Showing Results 1 - 2 of 2